March 2007- BioMarker Strategies signs sponsored research agreement with Johns Hopkins.

July 30, 2007- State of Maryland designates Biomarker Strategies as a “Qualified Maryland Biotechnology Company” and approves initial investor applications for the MD Biotechnology Investment Tax Credit Program.

December 14, 2007- The company closes initial angel investment round after raising significant amounts of start-up capital from high net worth investors, including funds raised through the Maryland Biotech Investment Tax Credit Program.

December 24, 2007- BioMarker Strategies signs lease to become one of the first commercial tenants of the Science & Technology Park at Johns Hopkins (www.scienceparkjohnshopkins.net).

Press Releases:
Baltimore Business Journal
Baltimore Daily Record
Forest City-New East Baltimore Partnership
Globest Newsletter

January 1, 2008- BioMarker Strategies joins BIO, the National Biotechnology Industry Organization (www.bio.org). The company is also a member of the Maryland Tech Council/Maryland BIO.

February 1, 2008- BioMarker Strategies joins the Personalized Medicine Coalition (www.personalizedmedicinecoalition.org).

March 1, 2008- BioMarker Strategies joins Advamed (www.advamed.org), the national medical device industry association.

June 1, 2008- BioMarker Strategies signs collaborative agreement with Xceed Molecular.

June 19th, 2008- Dr. Douglas Clark, Chairman & CEO, is a presenter at the National BIO Annual Meeting at a session titled: "Drug/Diagnostic Development-Clinical Validation and Personalized Medicine"

July 1, 2008- BioMarker Strategies becomes one of the first commercial tenants of the Science + Technology Park at Johns Hopkins.

Please send media inquiries to info@biomarkerstrategies.com or you can contact Scott Allocco at 410-532-2641.